Literature DB >> 3616852

Ceftriaxone for treatment of primary syphilis in men: a preliminary study.

T T Moorthy, C T Lee, K B Lim, T Tan.   

Abstract

Eighteen male patients with primary syphilis were randomly assigned to one of the following treatment schedules: ceftriaxone (3 g in a single intramuscular [im] injection), ceftriaxone (2 g im daily for two days), ceftriaxone (2 g im daily for five days), and benzathine penicillin (2.4 X 10(6) units in a single im injection). The single 3-g dose of ceftriaxone cured three men, one had a sustained response, and one failed to be cured. Of the patients given 2 g of ceftriaxone im daily for two days, three were cured and two had a sustained response. All three men treated with 2 g of ceftriaxone daily for five days had a sustained response. In the group given penicillin, three men were cured, one had a sustained response, and one was lost to follow-up.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3616852     DOI: 10.1097/00007435-198704000-00013

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Treating Syphilis: Examining therapeutic approaches to this STD.

Authors:  W D Colby
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

Review 3.  Treatment of sexually transmitted bacterial diseases in pregnant women.

Authors:  G G Donders
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 5.  Global challenge of antibiotic-resistant Treponema pallidum.

Authors:  Lola V Stamm
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

7.  Efficacy of cefmetazole in the treatment of active syphilis in the rabbit model.

Authors:  S A Baker-Zander; S A Lukehart
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 8.  Syphilis in the HIV-infected patient: an update on epidemiology, diagnosis, and management.

Authors:  Jonathan Zellan; Michael Augenbraun
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.495

9.  The Diagnosis and Management of Syphilis in the HIV-Infected Patient.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.663

Review 10.  Comparison of efficacy of treatments for early syphilis: A systematic review and network meta-analysis of randomized controlled trials and observational studies.

Authors:  Hong-Ye Liu; Yan Han; Xiang-Sheng Chen; Li Bai; Shu-Ping Guo; Li Li; Peng Wu; Yue-Ping Yin
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.